BioNxt Solutions Inc. (OTCMKTS:BNXTF) Short Interest Up 156.1% in February

BioNxt Solutions Inc. (OTCMKTS:BNXTF) saw a significant increase in short interest in the month of February. As of February 15th, there was short interest totalling 10,500 shares, an increase of 156.1% from the January 31st total of 4,100 shares. Based on an average daily volume of 32,100 shares, the short-interest ratio is currently 0.3 days.

BioNxt Solutions Trading Up 2.1 %

Shares of BNXTF traded up $0.01 during mid-day trading on Friday, reaching $0.35. The company had a trading volume of 200 shares, compared to its average volume of 10,361. The stock has a market cap of $39.66 million, a price-to-earnings ratio of -8.74 and a beta of 0.69. The firm has a fifty day simple moving average of $0.29 and a 200-day simple moving average of $0.22. BioNxt Solutions has a fifty-two week low of $0.11 and a fifty-two week high of $0.49.

BioNxt Solutions (OTCMKTS:BNXTF) last posted its quarterly earnings results on Friday, November 29th. The company reported ($0.01) earnings per share (EPS) for the quarter.

About BioNxt Solutions

BioNxt Solutions Inc engages in generation drug formulations and delivery system in Korea, Austria, Germany, and Switzerland. The company provides drug delivery methods, such as transdermal patches and oral dissolvable films designed for delivery of neurological medications. It offers point-of-care diagnostic, including covid-19 PCR diagnostic kit, a covid rapid test; peri-implantitis Oral Biosensor, allows early detection of infection associated with dental implants; and H1N1 (Swine Flu) and H5N1 (Avian Flu) oral biosensors for early detection of highly pathogenic influenza a strains.